January 6, 1999
To build on the success of its international programs, Johns Hopkins Medicine (JHM) has established a new organization, Johns Hopkins International L.L.C. (JHI), to centralize and facilitate international initiatives and activities. Steven J. Thompson, who will retain his current positions as JHM's vice dean for administration and CEO of Johns Hopkins Singapore, has been appointed CEO of JHI.
"During the past several years, we've shown that the Johns Hopkins Medicine brand of quality can open doors to new opportunities and new activities around the world," says Edward D. Miller, M.D., CEO of JHM and dean of the Johns Hopkins University School of Medicine. "Johns Hopkins International is a logical extension of this success. In a marketplace that is becoming truly global, it makes good business sense and good health care sense to take Hopkins' quality around the world."
According to Thompson, JHI will serve as the corporate arm of JHM that enters into international agreements. In addition, JHI will focus on directing patients to Hopkins in Baltimore when appropriate, assist faculty, staff and administration in dealing with international health care issues, and develop new international business opportunities.
"The international opportunities for Johns Hopkins are endless," Thompson says. "The recognition of the Johns Hopkins name worldwide can be parlayed into programs that help Hopkins to sustain its programs in teaching, research and patient care here and abroad."
Components of JHI include telemedicine, an area of medicine that Hopkins has helped pioneer, international patient services, international health care consulting services, Johns Hopkins Singapore and Johns Hopkins Singapore Clinical Services. John Hutchins will continue to direct the highly successful international patient services branch of JHI, while Carey Kriz, former research associate in the Department of Radiology, has been named director of strategy and business development for JHI.
Initial business objectives call for increasing the number of international patients coming to Hopkins in Baltimore by at least 10 percent this year. To this end, JHI is exploring the establishment of regional referral centers in Abu Dhabi, the United Arab Emirates, Mumbai, India, and Singapore, as well as several diagnostic clinics with telemedical links to Hopkins.
Hopkins' international health care consulting business also will be strengthened, helping clients build clinical programs and develop improved hospital administration systems. JHI also plans to expand its telemedicine capabilities beyond its involvement with WorldCare, the consortium of several major U.S. medical centers formed last year to serve international patients, and Intermed, an ongoing telemedicine project between Hopkins and Turkey.
"The time is right for Johns Hopkins International," says Miller. "We see more than 6,000 international patients a year at Hopkins in Baltimore. Johns Hopkins International is the vehicle that will continue our momentum in this important emerging market."